TELEFLEX INCORPORATED (TFX) FY2026 YTD Q2 P&L / Income Statement

TELEFLEX INCORPORATED (TFX) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net revenues

1,118,594,000 US dollars

Cost of goods sold

479,461,000 US dollars

Gross profit

639,133,000 US dollars

Operating expenses (calculated)

546,126,000 US dollars

Income from continuing operations before interest, taxes and loss on extinguishment of debt

93,007,000 US dollars

Other income (expense), net (calculated)

negative 51,697,000 US dollars

Income from continuing operations before taxes

41,310,000 US dollars

Taxes on income from continuing operations

4,386,000 US dollars

Net income

91,539,000 US dollars

Vascular

483,149,000 US dollars

Interventional

416,530,000 US dollars

Surgical

218,915,000 US dollars

Selling, general and administrative expenses

439,527,000 US dollars

Research and development expenses

89,508,000 US dollars

Restructuring charges, separation costs and impairment charges

17,091,000 US dollars

Income from discontinued operations

54,615,000 US dollars. Reported below-tax contribution to net income.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.